| Literature DB >> 25022716 |
Elisabeth Mamelle1, Isabelle Borget, Sophie Leboulleux, Haïtham Mirghani, Carlos Suárez, Phillip K Pellitteri, Ashok R Shaha, Marc Hamoir, K Thomas Robbins, Avi Khafif, Juan P Rodrigo, Carl E Silver, Alessandra Rinaldo, Alfio Ferlito, Dana M Hartl.
Abstract
Prophylactic neck dissection (PND) for papillary thyroid carcinoma (PTC) is controversial. Our aim was to assess current levels of evidence (LE) according to the Oxford Centre for Evidence-based Medicine ( http://www.cebm.net/?O=1025 ) regarding the oncologic benefits of PND. Data were analyzed via MEDLINE keywords: PTC, differentiated thyroid carcinoma, PND, central lymph node metastases, central compartment, recurrence-free survival. There was conflicting evidence regarding the rate of reoperation for recurrence, with some studies showing a lower rate after PND with increased recurrence-free survival and a higher rate of undetectable pre- and post-ablation thyroglobulin levels (LE 4), whereas other studies did not show a difference (LE 4). Only one study (LE 4) showed improved disease-specific survival with PND. PND may improve recurrence-free survival, although this is supported by only a low LE. Current recommendations can only be based on low-level evidence.Entities:
Mesh:
Year: 2014 PMID: 25022716 PMCID: PMC4986511 DOI: 10.1007/s00405-014-3104-5
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503